IA2030 Scorecard
—Global
Type to select a Country
SP 6: Supply & Sustainability
6.1
Healthy global markets for vaccines
Level of health of the vaccine market—Global
| Vaccine | Baseline (2019/2020) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Bacille Calmette-Guerin (BCG)1 | Not applicable | Unhealthy | Healthy | Healthy | Healthy |
| Cholera | Not applicable | Not applicable | Concerning | Unhealthy | Unhealthy |
| Hexa (acellular pertussis-containing)2 | Not applicable | Unhealthy | Unhealthy | Unhealthy | Unhealthy |
| Human papillomavirus (HPV) | Not applicable | Concerning | Unhealthy | Concerning | Concerning |
| Inactivated polio vaccine, stand-alone | Not applicable | Healthy | Concerning | Healthy | Healthy |
| Measles | Not applicable | Concerning | Not applicable | Not applicable | Not applicable |
| Measles-mumps-rubella (MMR)2 | Not applicable | Concerning | Concerning | Concerning | Concerning |
| Measles-rubella | Not applicable | Concerning | Concerning | Concerning | Concerning |
| Penta (whole-cell pertussis-containing) | Not applicable | Healthy | Healthy | Healthy | Healthy |
| Pneumococcal conjugate vaccine (PCV)2 | Not applicable | Concerning | Healthy | Healthy | Healthy |
| Pneumococcal polysaccharide2 | Not applicable | Concerning | Not applicable | Not applicable | Not applicable |
| Rotavirus | Not applicable | Healthy | Concerning | Concerning | Concerning |
| Tetanus-diphtheria2 | Not applicable | Healthy | Healthy | Healthy | Healthy |
| Yellow fever | Not applicable | Not applicable | Concerning | Concerning | Concerning |
1) No market study update in 2020 - same as 2019.
2) No market study update - same as 2020.
Definition: Level of health of the global market.
- Healthy: The market has a diverse and stable supplier base
- Concerning: The market has a significant concentration of vaccine supply with a potential for market disruption
- Unhealthy: The market does not have a stable and diverse supply
Method of estimation:
2019/2020 & 2021:
2022:
Step 1) For each antigen, conduct a review and sum the number of criteria for a healthy market ‘met’ in the most recent market assessment.
The overall health of a vaccine market includes an assessment of the following criteria:
- Total number of suppliers
- Relative concentration among suppliers (market share of the two largest producers)
- Ability to distribute globally
- State of the development pipeline - the number of vaccines in phase III clinical development
Step 2) Determine the level of health based on the conditions outlined below.
2019/2020 & 2021:
- Healthy: First three criteria are positive and the last is not negative.
- Concerning: One of the first three criteria is negative or all of the first three criteria are neutral and the fourth is negative.
- Unhealthy: Two or more of the first three criteria are negative.
2022:
- Healthy: Most scores are positive across the four criteria.
- Concerning: Most scores are neutral across the four criteria.
- Unhealthy: Most scores are negative across the four criteria.
- Only the first three criteria are used for assessment if information on the fourth (number of vaccines in phase III clinical development) is missing.
Limitations: Flexibility given to accommodate specific needs of different market contexts may come with additional subjectivity that may pose challenges in reaching assessment alignment.
Data source: UNICEF Supply Division, Market Information for Access (MI4A) vaccine purchase database (contains information on vaccine prices, volumes, manufacturers, procurement modalities, contract length, and more as reported through WHO/UNICEF Joint Reporting Form, Gavi Secretariat, BMGF
Accessed: undefined
